Notice2025-11920
Change in Federal Payment and Collection Options
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
June 27, 2025
Issuing agencies
Health and Human Services DepartmentFood and Drug Administration
Abstract
The Food and Drug Administration (FDA or Agency) is providing notice that, effective October 1, 2025, it will no longer use paper- based (checks, bank drafts, money orders, etc.) methods for federal payments (any payment made by an agency) or collections (the transfer of monies from a source outside the Federal Government to an agency or to a financial institution acting as an agent of the Government) except in limited circumstances where an exemption or waiver exists.
Full Text
<html>
<head>
<title>Federal Register, Volume 90 Issue 122 (Friday, June 27, 2025)</title>
</head>
<body><pre>
[Federal Register Volume 90, Number 122 (Friday, June 27, 2025)]
[Notices]
[Pages 27639-27640]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2025-11920]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2025-N-1687]
Change in Federal Payment and Collection Options
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA or Agency) is providing
notice that, effective October 1, 2025, it will no longer use paper-
based (checks, bank drafts, money orders, etc.) methods for federal
payments (any payment made by an agency) or collections (the transfer
of monies from a source outside the Federal Government to an agency or
to a financial institution acting as an agent of the Government) except
in limited circumstances where an exemption or waiver exists.
FOR FURTHER INFORMATION CONTACT: Olufunmilayo Ariyo, Office of
Financial Management, Food and Drug Administration, 10903 New Hampshire
Ave, Silver Spring, MD 20993, 240-402-4989; or the User Fees Support
Staff at <a href="/cdn-cgi/l/email-protection#3f70701270797d7e12707972126a796c6c127850495a4d51525a514b7f595b5e1157574c11585049"><span class="__cf_email__" data-cfemail="6b242446242d292a46242d26463e2d3838462c041d0e1905060e051f2b0d0f0a45030318450c041d">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION:
I. Background
Federal payments will be made electronically unless the recipient
qualifies for a waiver under 31 CFR part 208. All collections will be
processed electronically unless the individuals or entities do not have
access to banking services or electronic payment systems; or they
qualify for an exception under applicable law. These changes do not
apply to national security- or law enforcement-related activities where
non-electronic fund transfer transactions are necessary or desirable.
This policy aligns with Executive Order (E.O.) 14247, Advancing
Federal Digital Services, which directs agencies to improve public-
facing digital services and reduce reliance on outdated, manual, or
paper-based processes, and E.O. 14249, Modernizing Financial
Transactions, requiring modernization of federal financial transactions
by accelerating the shift toward secure electronic payments and
collections, phasing out inefficient legacy methods.
This change has a direct impact on the fiscal year 2026 collections
for the following FDA User Fee programs:
<bullet> Animal Drug User Fee Act (ADUFA)
<bullet> Animal Generic Drug User Fee Act (AGDUFA)
<bullet> Prescription Drug User Fee Amendments (PDUFA)
<bullet> Medical Device User Fee Amendments (MDUFA)
<bullet> Generic Drug User Fee Amendments (GDUFA)
<bullet> Biosimilar User Fee Amendments (BsUFA)
<bullet> Over-the-Counter Monograph Drug User Fee Program (OMUFA)
<bullet> Food Safety Modernization Act (FSMA)
<bullet> Compounding Quality Act (CQA)
<bullet> Priority Review Vouchers (PRV)
<bullet> Mammography Quality Standards Act (MQSA)
<bullet> Tobacco User Fees under Section 919 of the Federal Food, Drug,
and Cosmetic Act (FD&C Act)
<bullet> Export Certificates under Section 801(e)(4)(B) of the FD&C Act
<bullet> Color Additive Certification under section 721 of the FD&C Act
<bullet> Fees collected under the Freedom of Information Act.
Individuals, corporations, or other public or private entities that
qualify for an exemption from the use of electronic funds transfers
should reach out to the User Fees Support Staff at <a href="/cdn-cgi/l/email-protection#d59a9af89a939794f89a9398f880938686f892baa3b0a7bbb8b0bba195b3b1b4fbbdbda6fbb2baa3"><span class="__cf_email__" data-cfemail="e2adadcfada4a0a3cfada4afcfb7a4b1b1cfa58d9487908c8f878c96a2848683cc8a8a91cc858d94">[email protected]</span></a> for assistance.
II. Electronic Collection Methods
Beginning on October 1, 2025, payments made to FDA must be made in
U.S. currency drawn on a U.S. bank by electronic check, credit card, or
wire transfer. The preferred method for payments to FDA is online using
electronic check (Automated Clearing House (ACH), also known as eCheck)
or credit card (Discover, VISA, MasterCard, American Express). FDA has
partnered with the U.S. Department of the Treasury to utilize <a href="http://Pay.gov">Pay.gov</a>,
a web-based
[[Page 27640]]
payment application, for online electronic payment. The <a href="http://Pay.gov">Pay.gov</a> feature
is available on the FDA website upon receipt of an invoice or after
completing the User Fee Cover Sheet and generating the user fee ID
number.
Secure electronic payments to FDA can be submitted using the User
Fees Payment Portal at <a href="https://userfees.fda.gov/pay">https://userfees.fda.gov/pay</a>. (Note: Only full
payments are accepted; no partial payments can be made online.) Once an
invoice or cover sheet is located, ``Pay Now'' should be selected to be
redirected to <a href="http://Pay.gov">Pay.gov</a>. Electronic payment options are based on the
balance due. Payment by credit card is available for balances less than
$25,000. If the balance exceeds this amount, only the ACH option is
available. Payments must be made using U.S. bank accounts as well as
U.S. credit cards.
For payments made by wire transfer, include the unique user fee ID
or invoice number to ensure that the payment is applied to the correct
fee(s). Without the unique user fee ID or invoice number, the payment
may not be applied. If the payment amount is not applied, the invoice
balance due amount will be referred to collections. The originating
financial institution may charge a wire transfer fee. Include
applicable wire transfer fees with payment to ensure fees are fully
paid. Questions about wire transfer fees should be addressed to the
financial institution. The following account information should be used
to send payments by wire transfer: U.S. Department of the Treasury,
TREAS NYC, 33 Liberty St., New York, NY 10045, Account No: 75060099,
Routing No. 021030004, SWIFT: FRNYUS33. FDA's tax identification number
is 53-0196965.
III. Electronic Federal Payment Methods
All entities receiving funds from FDA, including but not limited to
vendors or other entities receiving reimbursements or refunds, must
have a valid and active electronic payment method on file with the
Agency, such as ACH Direct Deposit or other Treasury-authorized payment
methods (FedWire or International ACH). Failure to provide this
information may result in delays in payment or inability to receive
funds.
Dated: June 24, 2025.
Grace R. Graham,
Deputy Commissioner for Policy, Legislation, and International Affairs.
[FR Doc. 2025-11920 Filed 6-26-25; 8:45 am]
BILLING CODE 4164-01-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on June 27, 2025.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.